Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997–2011
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997–2011 ; volume:14 ; number:1 ; day:11 ; month:6 ; year:2014 ; pages:1-10 ; date:12.2014
BMC infectious diseases ; 14, Heft 1 (11.6.2014), 1-10, 12.2014
- Creator
-
Martin, David A.
- Contributor
-
Luz, Paula M.
Lake, Jordan E.
Clark, Jesse L.
Veloso, Valdilea G.
Moreira, Ronaldo I.
Cardoso, Sandra W.
Klausner, Jeffrey D.
Grinsztejn, Beatriz
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-322
- URN
-
urn:nbn:de:1111-2016030317343
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Martin, David A.
- Luz, Paula M.
- Lake, Jordan E.
- Clark, Jesse L.
- Veloso, Valdilea G.
- Moreira, Ronaldo I.
- Cardoso, Sandra W.
- Klausner, Jeffrey D.
- Grinsztejn, Beatriz
- SpringerLink (Online service)
Other Objects (12)
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Interruption of antiretroviral treatment in HIV-infected children
Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Interruption of antiretroviral treatment in HIV-infected children
Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Interruption of antiretroviral treatment in HIV-infected children
Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)